Tazomeline

CAS No. 131987-54-7

Tazomeline( —— )

Catalog No. M36235 CAS No. 131987-54-7

Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 148 In Stock
10MG 221 In Stock
25MG 372 In Stock
50MG 518 In Stock
100MG 703 In Stock
200MG 918 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tazomeline
  • Note
    Research use only, not for human use.
  • Brief Description
    Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.
  • Description
    Tazomeline is a selective M1 muscarinic receptor agonist. Tazomeline inhibits twitch height in rabbit vas deferens(IC50= 0.001 nM). Tazomeline can be used for research of neuropsychiatric disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    131987-54-7
  • Formula Weight
    297.48
  • Molecular Formula
    C14H23N3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(CCCCCC)C=1C(=NSN1)C=2CN(C)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sauerberg P, et al. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines . J Med Chem. 1992 Jun 12;35(12):2274-83.?
molnova catalog
related products
  • tiquizium

    Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.

  • NS3861

    NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and bind with high affinity to heteromeric α3β4 and α4β2 nAChRs.

  • M4 mAChR agonist-1?

    M4 mAChR agonist-1 is an effective agonist of M4 mAChR (EC50 >10 μM).